This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
Since January 1, Vipshop Holdings Ltd Sponsored ADR (VIPS) has jumped 40.3%. Vipshop Holdings operates as an online discount retailer for various brands in the People’s Republic of China. For more information, get Portfolio Grader’s complete analysis of VIPS stock.
Shares of Stamps.com (STMP) have leaped 40.5% since January 1. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.
The price of Grupo Financiero Galicia SA Sponsored ADR Class B (GGAL) has seen a 42.9% boost since the first of the year. Grupo Financiero Galicia is a financial services holding company. The stock currently has a trailing PE Ratio of 7.20. For more information, get Portfolio Grader’s complete analysis of GGAL stock.
China Biologic Products, Inc. (CBPO) has risen 43.1% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
Since January 1, Sucampo Pharmaceuticals, Inc. Class A (SCMP) has climbed 47.1%. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.
The price of Insperity, Inc. (NSP) is up 48.7% since the first of the year. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.
Since January 1, the price of Impax Laboratories, Inc. (IPXL) has grown 59.7%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.
Since January 1, Ebix, Inc. (EBIX) has shot up 71.3%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. Trade volume has increased significantly over the past week, up 128.3%. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
Since January 1, ABIOMED, Inc. (ABMD) has jumped 83.4%. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Since the first of the year, the price of Chimera Investment Corporation (CIM) has swelled 361.8%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.50. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
